Delivered engineered strains and bioprocesses for production of human breast milk glycoproteins.
Fundraising: secured $4MM in an oversubscribed seed round and $20MM in Series A financing.
Established a platform to produce palm oil in oleaginous yeast.
We deliver successful projects
Engineered strains for improved cellulose degradation, glycolytic flux, productivity and titer.
Delivered new P&I and process flow diagrams including new unit ops to improve substrate utilization and mitigate contamination.
BIOTECH AND BIOPHARMA CONSULTING
Medical Device (IVD) Development
Led the development of a rapid (<10 minute) mulitplex real-time PCR diagnostic device, instrument and assay, from concept to 510k readiness including all DHF documentations (FMEAs, PRA, URRA, PRD, MRD, etc.)
Led the Verification for device and consumable.
Delivered novel DNA/RNA collection, extraction and preservation techniques.
Authored a patent on a novel cell-lysis product for gram+ and fungal pathogens.
Designed a cGMP-compliant cleanroom facility for manufacture of skin probiotics.
Scaled fermentation from bench to 5L and 50L.
Methane/Natural Gas bioconversion
Achieved KPIs for 2,3-BDO scale-up nearly 6 months ahead of schedule.
Launched a robust, internal Multi-omics core facility.
Managed an international protein engineering and high throughput screening project with ILH.
Delivered enzymes with improved substrate specificity.
Delivered 10% improved strain/process for Spinosad using an improved high throughput screening platform.
Delivered 20% improved strain for Spinetoram using a novel genetic engineering approach.
Achieved approval for Inatreq® precursor (UK-2A). Performed risk reviews, improved strains and processes.
Commissioned and Qualified two ISO-6/7 cleanrooms.
Received approval for development of a novel “green” biosurfactant (soap).